These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 25924577)
1. Changes in clinical trial length. Pregelj L; Verreynne ML; Hine D Nat Rev Drug Discov; 2015 May; 14(5):307-8. PubMed ID: 25924577 [No Abstract] [Full Text] [Related]
2. Relationship between drug lag and factors associated with clinical trials in Japan. Ohwaki K; Nakabayashi T J Clin Pharm Ther; 2014 Dec; 39(6):649-52. PubMed ID: 25200123 [TBL] [Abstract][Full Text] [Related]
4. A proof-of-concept clinical trial design combined with dose-ranging exploration. Wang X; Ting N Pharm Stat; 2012; 11(5):403-9. PubMed ID: 22714951 [TBL] [Abstract][Full Text] [Related]
5. A semiparametric model for regression analysis of interval-censored failure time data. Finkelstein DM; Wolfe RA Biometrics; 1985 Dec; 41(4):933-45. PubMed ID: 3830259 [TBL] [Abstract][Full Text] [Related]
6. Central nervous system drug development, basic, and clinical research: thinking outside the box. Klein DF; Glick ID; Shader RI J Clin Psychopharmacol; 2011 Oct; 31(5):553-4. PubMed ID: 21869701 [No Abstract] [Full Text] [Related]
7. Adaptive design may hasten clinical trials. Schmidt C J Natl Cancer Inst; 2007 Jan; 99(2):108-9. PubMed ID: 17227993 [No Abstract] [Full Text] [Related]
8. Establishing consistency across all regions in a multi-regional clinical trial. Tsou HH; James Hung HM; Chen YM; Huang WS; Chang WJ; Hsiao CF Pharm Stat; 2012; 11(4):295-9. PubMed ID: 22504851 [TBL] [Abstract][Full Text] [Related]
9. Nonparametric estimation of duration of accrual and total study length for clinical trials. Morgan TM Biometrics; 1987 Dec; 43(4):903-12. PubMed ID: 3427175 [TBL] [Abstract][Full Text] [Related]
10. Overview of recruitment to the coronary primary prevention trial. Marshall GD Circulation; 1982 Dec; 66(6 Pt 2):IV5-9. PubMed ID: 7127722 [No Abstract] [Full Text] [Related]
11. The application of the principles of clinical drug development to a pharmacological challenge test of the serotonergic system. Pinder RM J Psychopharmacol; 2004 Mar; 18(1):17; author reply 18-9. PubMed ID: 15107179 [No Abstract] [Full Text] [Related]
12. Therapeutic trials in ALS. Bradley W Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):6-7. PubMed ID: 12745610 [No Abstract] [Full Text] [Related]
13. Evaluating statistics in clinical trials: making the unintelligible intelligible. Gilmore SJ Australas J Dermatol; 2008 Nov; 49(4):177-84; quiz 185-6. PubMed ID: 18855776 [TBL] [Abstract][Full Text] [Related]
15. Evaluation and recommendations on adaptive dose-ranging trials: highlights from the PhRMA Adaptive Dose-Ranging Studies Working Group. Pinheiro J J Clin Pharmacol; 2010 Sep; 50(9 Suppl):47S-49S. PubMed ID: 20881216 [No Abstract] [Full Text] [Related]
16. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials. Tamura RN; Huang X Clin Trials; 2007; 4(4):309-17. PubMed ID: 17848492 [TBL] [Abstract][Full Text] [Related]